![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hadziyannis Stephanos J Papatheodoridis George V
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.9, Iss.2, 2004-11, pp. : 207-221
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging Treatments for Autoimmune Hepatitis
Current Drug Targets. Inflammation & Allergy, Vol. 1, Iss. 4, 2002-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging treatments for hepatitis C
By Flisiak Robert Jaroszewicz Jerzy Parfieniuk-Kowerda Anna
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging treatments for chronic constipation
By Gudsoorkar Vineet S Quigley Eamonn MM
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for hepatitis B
Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Chronic Hepatitis B
Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. :